Outset Medical, Inc.

OM - Financial Snapshot

Metrics for OM

Price $5.04
Shares Outstanding 18.15M
All-Time Low $3.10
52-Week Low $3.10

Balance Statement Metrics

Net Cash / Share $2.41
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Net Current Assets / Share $7.19
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $7.84
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Shares Outstanding Ave Change (Annual) 3.87%
Shares Δ YoY 5.22%

Income Metrics

Max Earning Power / Share $-6.79
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $-9.36
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 1.11%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Data as of: Price 02-03-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 2-1-2026
Income indicators Value Date
EBITDA Positive No 2-1-2026
Net Income Positive No 2-1-2026
Avg CA Burn (Annual %) -14.07% 2-1-2026
Avg CA Burn (Quarterly %) -0.69% 2-1-2026

Shares Outstanding Changes

Date Shares Outstanding Delta
No recent share changes

Short Interest Changes

Latest short interest: 2,293,147 shares (12.77% of float) | Days to cover: 1.37

Date Short Interest Delta Δ %
2026-02-03 2,293,147 shares +0 +0.00%
2026-02-02 2,293,147 shares +0 +0.00%
2026-01-30 2,293,147 shares None

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
2026-01-12 24,585,695 18,153,090 135.44% $5.57

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.